PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10631097-0	2000	Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.	Lovastatin	147-157	interleukin 6	Homo sapiens	46-59	
10631097-7	2000	Lovastatin markedly inhibited mesangial cell expression of IL-6 mRNA and reduced IL-6 secretion.	Lovastatin	0-10	interleukin 6	Homo sapiens	59-63	
10631097-7	2000	Lovastatin markedly inhibited mesangial cell expression of IL-6 mRNA and reduced IL-6 secretion.	Lovastatin	0-10	interleukin 6	Homo sapiens	81-85	
25374755-12	2014	Activated BEAS-2B cells treated with lovastatin exhibited reduced IL-6, eotaxins (CCL11 and CCL24), and intercellular adhesion molecule-1 protein expression.	Lovastatin	37-47	interleukin 6	Homo sapiens	66-70	
34607230-8	2021	Besides, in patients, receiving lovastatin the CRP, IL-6, IL-8 levels were significantly decreased from T1 to T3 than to the control group.	Lovastatin	32-42	interleukin 6	Homo sapiens	52-56	
31013450-4	2019	Lovastatin treatment resulted in increased levels of IL-6, IL-12p40, and IFN-gamma mRNA in both PBMCs and monocytes following LPS stimulation compared with control cells.	Lovastatin	0-10	interleukin 6	Homo sapiens	53-57	
15378516-9	2004	Furthermore, lovastatin is able to suppress microglial tumor necrosis factor-alpha, interleukin (IL)-beta1 and IL-6 production promoted either by IFN-gamma or by Abeta peptide challenge in the presence of CD40 cross-linking.	Lovastatin	13-23	interleukin 6	Homo sapiens	111-115	
20214221-7	2009	Lovastatin administration resulted in the significant decrease of the pro-inflammatory cytokines IL-6 and TNF-alfa, while that of fluvastatin brought about the significant decrease of the serum levels of IL-6, IL-8 and TNF-alfa.	Lovastatin	0-10	interleukin 6	Homo sapiens	97-101	
20214221-10	2009	CONCLUSIONS: Lovastatin and fluvastatin, significantly decrease the level of viremia, of IL-6 and TNF-alpha in the patients with chronic hepatitis C.	Lovastatin	13-23	interleukin 6	Homo sapiens	89-93	
16968805-13	2006	Lovastatin significantly decreased Rho kinase and nuclear factor-kappaB activity, significantly increased Akt activity, and resulted in decreased monocyte IL-6 levels; these effects were reversed with mevalonate and geranylgeranyl pyrophosphate, indicating direct effects of statins on protein prenylation.	Lovastatin	0-10	interleukin 6	Homo sapiens	155-159